Geographical clustering of high risk sexual behaviors in "hot-spots" for HIV and sexually transmitted infections in Kwazulu-Natal, South Africa

Gita Ramjee, Handan Wand, Gita Ramjee, Handan Wand

Abstract

We investigated geographical variations of three sexually transmitted infections (STIs) namely chlamydia, gonorrhea and syphilis in the greater Durban area, so as to optimize intervention strategies. The study population was a cohort of sexually active women who consented to be screened in one of three biomedical studies conducted in Durban. A total of nine local regions collectively formed three clusters at screening, five of which were previously defined as HIV hot-spots. STI cases were geo-coded at the census level based on residence at the time of screening. Spatial SaTScan Statistics software was employed to identify the areas with a disproportionate prevalence and incidence of STI infection when compared to the neighboring areas under study. Both prevalence and incidence of STIs were collectively clustered in several localized areas, and the majority of these locations overlapped with high HIV clusters and shared the same characteristics: younger age, not married/cohabitating and multiple sex partners.

Trial registration: ClinicalTrials.gov NCT00121459.

Figures

Fig. 1
Fig. 1
HIV/STI hot-spots

References

    1. UNAIDS. UNAIDS report on the global AIDS epidemic 2011. Geneva: UNAIDS; 2012.
    1. Chen L, Jha P, Stirling B, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. PLoS One. 2007;2(10):e1001. doi: 10.1371/journal.pone.0001001.
    1. Taha T, Hoover D, Dallabetta G, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998;12:1699–1706. doi: 10.1097/00002030-199813000-00019.
    1. Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and Human Immunodeficiency Virus acquisition in African women. J Infect Dis. 2008;197:548–554. doi: 10.1086/526496.
    1. van de Wijgert J, Morrison C, Cornelisse P, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. 2008;48:203–210. doi: 10.1097/QAI.0b013e3181743936.
    1. Ramjee G, Wand H, Whitaker C, et al. HIV incidence among non-pregnant women living in selected rural, semi-rural and urban areas in Kwazulu-Natal, South Africa. AIDS Behav. 2012;16(7):2062–71.
    1. Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS. 2012;26(3):375–380. doi: 10.1097/QAD.0b013e32834f990f.
    1. Ramjee G, Wand H. Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa. Bull World Health Organ. 2012;90(10):748–755. doi: 10.2471/BLT.12.105700.
    1. Wand H, Ramjee G. Targeting the hotspots: investigating spatial and demographic variations in HIV infection in small communities in South Africa. J Int AIDS Soc. 2010;13(1):41. doi: 10.1186/1758-2652-13-41.
    1. Wand H, Whitaker C, Ramjee G. Geoadditive models to assess spatial variation of HIV infections among women in local communities of Durban, South Africa. Int J Health Geogr. 2011
    1. Padian N, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251–261. doi: 10.1016/S0140-6736(07)60950-7.
    1. Nunn A, McCormack S, Crook A, Pool R, Rutterford C, Hayes R. Microbicides development programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009;10(1):99. doi: 10.1186/1745-6215-10-99.
    1. Ramjee G, Kapiga S, Weiss S, et al. The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study. J Acquired Immune Defic Syndr. 2008;47(1):93. doi: 10.1097/QAI.0b013e31815c71f7.
    1. Kulldorff M, Song C, Gregorio D, Samociuk H, DeChello L. Cancer map patterns: are they random or not? Am J Prev Med. 2006;30(2 Suppl):S37. doi: 10.1016/j.amepre.2005.09.009.
    1. Kulldorff M. Information Management Services, Inc: SaTScan version 7.0: software for the spatial and space-time scan statistics 2007.
    1. Kulldorff M. Commentary: geographical distribution of sporadic Creutzfeldt-Jakob disease in France. Int J Epidemiol. 2002;31(2):495–496. doi: 10.1093/ije/31.2.495.
    1. Nunes C. Tuberculosis incidence in Portugal: spatiotemporal clustering. Int J Health Geogr. 2007;6(1):30. doi: 10.1186/1476-072X-6-30.
    1. Risley CL, Ward H, Choudhury B, et al. Geographical and demographic clustering of gonorrhoea in London. Sexually Transm Infect. 2007;83(6):481–487. doi: 10.1136/sti.2007.026021.
    1. Hayes R, Watson-Jones D, Celum C, van de Wijgert J, Wasserheit J. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS. 2010;24:S15. doi: 10.1097/01.aids.0000390704.35642.47.
    1. Zuma K, Lurie M, Williams B, Mkaya-Mwamburi D, Garnett G, Sturm A. Risk factors of sexually transmitted infections among migrant and non-migrant sexual partnerships from rural South Africa. Epidemiol Infect. 2005;133(3):421–428. doi: 10.1017/S0950268804003607.
    1. Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sexually Transm Infect. 2011;87(3):183–190. doi: 10.1136/sti.2010.047514.
    1. Mavedzenge SN, Pol BVD, Cheng H, et al. Epidemiological synergy of trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis. 2010;37(7):460.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere